Page 100 - Bradken Annual Report 2013_Page flip

Basic HTML Version

Notes to the Consolidated Financial Statements
30 June 2013
64 BRADKEN LIMITED ANNUAL REPORT 2013
Notes to the consolidated financial statements
30 June 2013
(continued)
14 Intangible assets (continued)
(c)
(d)
15 Available for sale financial assets
2013
2012
$'000
$'000
At beginning of year
-
70,054
Additions / (Disposals)
-
(681)
Revaluation surplus/(deficit) transfer to equity
-
(33,061)
Transfers to investments accounted for using the equity method
-
(36,312)
At end of year
-
-
16 Investments accounted for using the equity method
2013
2012
$'000
$'000
Shares in associates (note 30)
49,261
38,521
49,261
38,521
17 Payables
2013
2012
$'000
$'000
Current
Trade payables
115,931
158,762
Other payables
81,098
44,483
197,029
203,245
Non current
Other payables
8,231
7,438
8,231
7,438
(a)
Australian Dollars
88,708
80,329
US Dollars
60,079
83,611
Chinese Yuan
35,686
33,721
Other *
20,787
13,022
205,260
210,683
(b)
* Other refers to a basket of currencies (Euros, Great British Pounds, Japanese Yen, New Zealand Dollars, Singapore Dollars, Malaysian
Ringgit, South African Rand, Chilean Pesos)
Impairment charge
There were no impairment charges in the period (2012: $NIL).
Foreign currency risk
Fair value
Due to the short term nature of these payables, their carrying value is assumed to approximate their fair value.
The carrying amounts of the Group's and parent entity's
payables are denominated in the following currencies:
The impairment testing highlights a reasonable buffer between the value-in-use amount and the net book value of assets of the
CGU's. Significant changes in the major assumptions would be required to generate an impairment charge.
Impact of possible changes in key assumptions
Page 64
Bradken Limited